← Pilgrims Pride overview

Pilgrims Pride vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Pilgrims Pride Corp (PPC)

Q3 2026
▲2▼2

JBS takeover bid lifts PPC as chicken margins collapse

  • Q2 profit crushed by falling chicken prices Pilgrim's Pride said quarterly net income fell to $13.2 million from $356 million a year earlier, as prices for commodity chicken cuts dropped more than 25%. Sales slipped 2.8% to $4.6 billion. Lower prices directly shrink profit per bird, pushing the stock down.

    This is the core fundamental driver of the period: collapsing chicken prices gutted earnings.

  • Analyst downgrade to Strong Sell on margin collapse Zacks downgraded PPC to Strong Sell after earnings missed estimates and gross profit was cut roughly in half. Management gave no specific guidance for the next quarter or year, and the stock is down about 31% this year. Downgrades can push investors to sell.

    The downgrade reflects and amplifies the earnings miss, adding selling pressure on the stock.

  • JBS bids to buy remaining PPC shares JBS, which already owns about 82% of Pilgrim's Pride, proposed an all-stock deal to buy the rest at $28.49 per share. That is a premium to the market price. Takeover offers usually lift the target stock toward the offer price, and PPC jumped 15%.

    The takeover bid is the biggest new event, directly boosting PPC shares.

  • BofA calls JBS bid attractive, deal likely Bank of America said the new all-stock structure is more attractive than JBS's 2021 cash offer, letting JBS consolidate PPC without spending cash. The deal still needs approval from independent directors and a majority of outside shareholders. Analyst support raises confidence the bid could succeed.

    This explains why the market sees the takeover as credible, supporting PPC's price.

August 2026
▲2▼2

JBS takeover bid lifts PPC as chicken margins collapse

  • Q2 profit crushed by falling chicken prices Pilgrim's Pride said quarterly net income fell to $13.2 million from $356 million a year earlier, as prices for commodity chicken cuts dropped more than 25%. Sales slipped 2.8% to $4.6 billion. Lower prices directly shrink profit per bird, pushing the stock down.

    This is the core fundamental driver of the period: collapsing chicken prices gutted earnings.

  • Analyst downgrade to Strong Sell on margin collapse Zacks downgraded PPC to Strong Sell after earnings missed estimates and gross profit was cut roughly in half. Management gave no specific guidance for the next quarter or year, and the stock is down about 31% this year. Downgrades can push investors to sell.

    The downgrade reflects and amplifies the earnings miss, adding selling pressure on the stock.

  • JBS bids to buy remaining PPC shares JBS, which already owns about 82% of Pilgrim's Pride, proposed an all-stock deal to buy the rest at $28.49 per share. That is a premium to the market price. Takeover offers usually lift the target stock toward the offer price, and PPC jumped 15%.

    The takeover bid is the biggest new event, directly boosting PPC shares.

  • BofA calls JBS bid attractive, deal likely Bank of America said the new all-stock structure is more attractive than JBS's 2021 cash offer, letting JBS consolidate PPC without spending cash. The deal still needs approval from independent directors and a majority of outside shareholders. Analyst support raises confidence the bid could succeed.

    This explains why the market sees the takeover as credible, supporting PPC's price.

Latest
▲2▼2

JBS takeover bid lifts PPC as chicken margins collapse

  • Q2 profit crushed by falling chicken prices Pilgrim's Pride said quarterly net income fell to $13.2 million from $356 million a year earlier, as prices for commodity chicken cuts dropped more than 25%. Sales slipped 2.8% to $4.6 billion. Lower prices directly shrink profit per bird, pushing the stock down.

    This is the core fundamental driver of the period: collapsing chicken prices gutted earnings.

  • Analyst downgrade to Strong Sell on margin collapse Zacks downgraded PPC to Strong Sell after earnings missed estimates and gross profit was cut roughly in half. Management gave no specific guidance for the next quarter or year, and the stock is down about 31% this year. Downgrades can push investors to sell.

    The downgrade reflects and amplifies the earnings miss, adding selling pressure on the stock.

  • JBS bids to buy remaining PPC shares JBS, which already owns about 82% of Pilgrim's Pride, proposed an all-stock deal to buy the rest at $28.49 per share. That is a premium to the market price. Takeover offers usually lift the target stock toward the offer price, and PPC jumped 15%.

    The takeover bid is the biggest new event, directly boosting PPC shares.

  • BofA calls JBS bid attractive, deal likely Bank of America said the new all-stock structure is more attractive than JBS's 2021 cash offer, letting JBS consolidate PPC without spending cash. The deal still needs approval from independent directors and a majority of outside shareholders. Analyst support raises confidence the bid could succeed.

    This explains why the market sees the takeover as credible, supporting PPC's price.

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.